LGC switches to renewable electricity in Germany

News - From January 2022, the electricity we purchase for five of our sites in Germany - Augsburg, Berlin, Kulmbach, Luckenwalde and Wesel - will be generated from 100% renewable sources.

26 January 2022
LGC appoints Vivid Sehgal as Chief Financial Officer

News - Replaces Simon Parsons, who will leave LGC after 11 years of service

17 January 2022
New LGC Chair in Measurement Science for Health appointed

News - LGC has co-sponsored a new Chair in Measurement Science at the University of Strathclyde in Glasgow, UK, to help advance innovation in the medical, food and drink, and high-value manufacturing industries in the UK.

14 January 2022
LGC reports half year trading in line with expectations

News - Update for the half year ended 30 September 2021

23 December 2021
LGC publishes ESG report for 2020-21

News - LGC's first ESG report using GRI Standards, the most widely used sustainability reporting framework 

01 December 2021
LGC to develop new Berlin site to expand Nucleic Acid Therapeutics capacity

News - Site will be dedicated to medium to large scale and early to late Phase Clinical GMP manufacturing of Nucleic Acid Therapeutics

15 November 2021
LGC’s commitment to carbon net zero

News - LGC is committing to being carbon net zero by 2050

10 November 2021
LGC supports British Pharmacopoeia 2022

Blog - LGC’s MHRA Laboratories Team supports the annual BP publication by providing physico-chemical analysis of substances

04 November 2021
LGC, Biosearch Technologies testing workflow underpins expansion of COVID-19 testing in New York

News - Nexar workflow continues to enable simple, scalable, and cost-effective testing 

29 October 2021
LGC instruments support important milestones

Blog - LGC’s validated technology provides gold-standard sensitivity and specificity based on clinical data, as well as material cost and time savings.

25 October 2021